申请人:Breitenstein Werner
公开号:US20080275127A1
公开(公告)日:2008-11-06
α-Amino hydroxamic acid derivative of the formula I,
in which R is C
2
-C
7
-alkyl, which is mono-, di- or trisubstituted by halogen, nitro, lower acyloxy, trifluoromethoxy, cyano, C
3
-C
5
-cycloalkyl or unsubstituted or substituted C
3
-C
6
-heteroaryl comprising one or two heteroatoms selected from the group consisting of O, S and N; or C
3
-C
7
-alkenyl or C
3
-C
7
-alkynyl, which in each case is unsubstituted or mono-, di- or trisubstituted by halogen, nitro, lower acyloxy, trifluoromethoxy, cyano, C
3
-C
5
-cycloalkyl or unsubstituted or substituted C
3
-C
6
-heteroaryl comprising one or two heteroatoms selected from the group consisting of O, S and N;
and the other symbols are as defined in claim
1,
are described.
These compounds are MMP and in particular MMP2 inhibitors and can be used for treatment of MMP dependent diseases, in particular inflammation conditions, rheumatoid arthritis, osteoarthritis, tumors (tumor growth, metastasis, progression or invasion) and pulmonary disorders (e.g. emphysema, COPD).
本文描述了公式I的α-氨基羟肟酸衍生物,其中R是C2-C7烷基,可以是单取代、双取代或三取代的卤素、硝基、低酰氧基、三氟甲氧基、氰基、C3-C5环烷基或未取代或取代的C3-C6杂环芳基,其中所述杂环芳基包括一个或两个从O、S和N组成的杂原子;或者是C3-C7烯基或C3-C7炔基,每种情况下都未取代或单取代、双取代或三取代的卤素、硝基、低酰氧基、三氟甲氧基、氰基、C3-C5环烷基或未取代或取代的C3-C6杂环芳基,其中所述杂环芳基包括一个或两个从O、S和N组成的杂原子;其他符号如权利要求1中所定义。这些化合物是MMP,特别是MMP2的抑制剂,并可用于治疗MMP依赖性疾病,特别是炎症病症、类风湿性关节炎、骨关节炎、肿瘤(肿瘤生长、转移、进展或侵袭)和肺部疾病(例如肺气肿、COPD)。